Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinsons Disease
NEJM 361:1268-1278, 1304, Olanow,C.,et al, 2009
See this aricle in Pubmed

Article Abstract
Early treatment with rasagiline at a dose of 1 mg per day provided benefits that were consistent with a possible disease-modifying effect, but early treatment with rasagiline at a dose of 2 mg per day did not. Because the two doses were associated with different outcomes, the study results must be interpreted with caution.
 
Related Tags
(click to filter results - removes previous filter)

controversies in neurology
monoamine oxidase inhibitors
neuroprotective agents
Parkinson disease
Parkinson disease,treatment of
rasagiline
treatment of neurologic disorder

Click Here to return To Results